David and thread,
Article on Venter in NY Times Science section today.
nytimes.com
An excerpt:
"Both Morgan and Collins are putting good money after bad," Dr. Venter says, referring to Dr. Michael Morgan, the Wellcome Trust's executive for genome sequencing and Dr. Francis Collins, director of the N.I.H.'s part of the human genome project. "Their plan is not to finish the genome," he says, but rather to prevent him from obtaining the only sequence and locking it up with patent claims.
An associate of Dr. Collins, Dr. Kathy Hudson, said that he remained "totally confident of the current human genome project strategy and that, "While Venter is certainly a fascinating personality, his every utterance does not seem to warrant a story in The New York Times."
Copyright by New York Times 1999
Regards,
Hal |
